Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial-July 2024-www.financetom.com

Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial

Sep 3, 2024 11:41 PM

Sept 3 (Reuters) - Athira Pharma ( ATHA ) said on

Tuesday its investigative drug failed to meet the main goal in a

mid-to-late stage trial in patients with mild-to-moderate

Alzheimer's disease.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： Baidu Proposes $2 Billion Exchangeable Bonds Offering Next page： BAT says court approves Canadian settlement plan

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Baidu Proposes $2 Billion Exchangeable Bonds Offering

Mar 7, 2025

04:03 AM EST, 03/07/2025 (MT Newswires) -- Baidu ( BIDU ) on Friday proposed to offer up to $2 billion in exchangeable bonds due 2032 outside the US. The bonds will reference ordinary shares of Trip.com ( TCOM ) that are listed on the Hong Kong stock exchange. The bonds are not exchangeable for Trip.com's ( TCOM ) American depository...

BAT says court approves Canadian settlement plan

Mar 7, 2025

March 7 (Reuters) - British American Tobacco ( BTI ) said on Friday its plan to settle a long-running tobacco lawsuit in Canada was approved by a court in the country. The settlement does not affect its outlook for 2025, the company said. ...

L&T bets on space exploration as India expands private rocket and satellite industry

Mar 7, 2025

BENGALURU, March 5 (Reuters) - The Indian industrial conglomerate Larsen & Toubro said it is betting on aerospace as a potential growth engine, including launch vehicle and satellite manufacturing, as the country cuts reliance on imports and boosts private participation. L&T, considered a bellwether for India's infrastructure spending because of how many industries its work touches, is the country's largest...

Update: Broadcom Fiscal Q1 Non-GAAP Earnings, Sales Rise; Q2 Outlook Beats; Shares Up Premarket

Mar 7, 2025

04:29 AM EST, 03/07/2025 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Broadcom ( AVGO ) shares were up nearly 13% in premarket activity Friday after the company reported overnight a fiscal Q1 earnings and sales beat, while its guidance for next quarter's sales was also above consensus. The company reported fiscal Q1...